Cochrane
Tracked across 3 events · 32 articles · First seen Feb 09, 2026 · Last active Apr 17, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Tech
Cochrane published a review challenging the effectiveness of intermittent fasting for weight loss, which could influence public health recommendations and dietary trends.
Feb 16, 2026 · 7 articles
Tech
Cochrane published a major review concluding that anti-amyloid drugs for Alzheimer's do not provide meaningful benefits to patients, challenging previous perceptions of these treatments.
Apr 16, 2026 · 7 articles
Tech
The Cochrane is represented by Rachel Richardson, who provided a cautious perspective on the study's findings, emphasizing the need for careful interpretation.
Feb 09, 2026 · 18 articles
95
Cochrane published review on anti-amyloid drugsCochrane Review Questions...
50
John Hardy (neuroscientist) criticized Cochrane review methodology CochraneCochrane Review Questions...
Eva Madrid
senior author
↔
Cochrane
Eva Madrid is a senior author of the Cochrane review on intermittent fasting.
Luis Garegnani
lead author
↔
Cochrane
Luis Garegnani is the lead author of the Cochrane review on intermittent fasting
Rachel Richardson
researcher at
↔
Cochrane
Rachel Richardson is a researcher at the Cochrane, offering an external perspect
Jörg Meerpohl
director
↔
Cochrane
Jörg Meerpohl is the director of Cochrane Germany, providing expert commentary.
NEWSDESK
Track Cochrane live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard